Advertisement

Pharmacy

Home Pharmacy
Add-on dupilumab reduces the rate of severe asthma exacerbations in uncontrolled asthma; it also reduces the glucocorticoid dose for glucocorticoid-treated asthma

Dupilumab Reduces Rate of Severe Asthma Exacerbations

And, add-on dupilumab reduces glucocorticoid dose in patients with glucocorticoid-treated asthma
Providers engaging parents hesitant about human papillomavirus vaccination and addressing their concerns can lead to same-day vaccinations

Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates

More adolescents receive HPV vaccination same day with physician engagement versus acquiescence
Offspring born to mothers with rheumatoid arthritis who are exposed to tumor necrosis factor α inhibitors in the gestational period do not have a significantly increased risk of serious infections

TNFi Exposure In Utero Does Not Up Serious Infection Risk

No increased risk of serious infection among RA offspring versus non-TNFi exposed or control
Overall

CDC: No Change in Level of Uninsured in U.S. in 2017

Five percent of children uninsured in 2017, 41.3 and 55.0 percent had public and private coverage
From 2000 through 2011 there was an increase in pediatric attention-deficit/hyperactivity disorder medication exposures reported to U.S. poison control centers

Increase in Pediatric ADHD Meds Exposures from 2000 to 2011

Intentional meds exposure most often reported among teens, accounting for half of teen exposure
For patients with suspected lower respiratory tract infection

Procalcitonin Assay Doesn’t Cut Antibiotic Use in Lower RTI

Provision of assay doesn't result in less antibiotic use for suspected lower respiratory tract infection
Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure
Semaglutide is safe and effective for the treatment of type 2 diabetes

Semaglutide Found to Be Effective Against Type 2 Diabetes

The once-weekly glucagon-like peptide 1 receptor agonist cuts HbA1c, body weight
For patients with active cancer and venous thromboembolism (VTE)

Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
Aimovig (erenumab-aooe) has been approved by the U.S. Food and Drug Administration to prevent migraine headaches in adults.

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo